TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+20.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$2.64B
(+15%)
Cap. Flow
-$3.06M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
38.92%
Holding
218
New
26
Increased
62
Reduced
55
Closed
4
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$15.6M |
| 2 |
Johnson & Johnson
JNJ
|
$14.4M |
| 3 |
Cigna
CI
|
$13.4M |
| 4 |
Abbott
ABT
|
$13M |
| 5 |
Milestone Pharmaceuticals
MIST
|
$11.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$146M |
| 2 |
UnitedHealth
UNH
|
$26M |
| 3 |
Humana
HUM
|
$10.7M |
| 4 |
Intuitive Surgical
ISRG
|
$9.93M |
| 5 |
Zoetis
ZTS
|
$7.76M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Real Estate | 3.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
76
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $8.12M | 0.31% | 524,896 +357,651 | +214% | +$5.53M |
|
77
Medical Properties Trust
MPW
$2.7B
| $7.9M | 0.3% | 374,289 +187,226 | +100% | +$3.95M |
|
78
Teva Pharmaceuticals
TEVA
$21.1B
| $7.7M | 0.29% | 785,851 | – | – |
|
|
LTC
79
LTC Properties
LTC
$1.68B
| $7.42M | 0.28% | 165,668 +20,247 | +14% | +$906K |
|
80
argenx
ARGX
$43.6B
| $7.22M | 0.27% | 44,977 +10,929 | +32% | +$1.75M |
|
81
Sutro Biopharma
STRO
$72.7M
| $7.05M | 0.27% | 641,268 | – | – |
|
|
SAGE
82
DELISTED
Sage Therapeutics
SAGE
| $6.95M | 0.26% | 96,211 +9,431 | +11% | +$681K |
|
|
SYNH
83
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.89M | 0.26% | 115,842 +69,860 | +152% | +$4.16M |
|
|
ALLK
84
DELISTED
Allakos
ALLK
| $6.81M | 0.26% | 71,396 +59,189 | +485% | +$5.64M |
|
85
Dentsply Sirona
XRAY
$2.85B
| $6.78M | 0.26% | 119,736 -17,200 | -13% | -$973K |
|
86
Iovance Biotherapeutics
IOVA
$807M
| $6.74M | 0.25% | 243,483 +68,471 | +39% | +$1.9M |
|
87
Arrowhead Research
ARWR
$3.05B
| $6.69M | 0.25% | 105,398 +74,698 | +243% | +$4.74M |
|
88
SPDR S&P Biotech ETF
XBI
$5.07B
| $6.47M | 0.24% | 68,037 -20,985 | -24% | -$2M |
|
89
Align Technology
ALGN
$10.3B
| $6.24M | 0.24% | 22,378 -5,900 | -21% | -$1.65M |
|
|
AVDL
90
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.15M | 0.23% | 814,588 | – | – |
|
91
Nektar Therapeutics
NKTR
$568M
| $6.12M | 0.23% | 283,679 | – | – |
|
92
Teleflex
TFX
$5.59B
| $5.88M | 0.22% | 15,608 +9,229 | +145% | +$3.47M |
|
|
ZGNX
93
DELISTED
Zogenix, Inc.
ZGNX
| $5.62M | 0.21% | 107,703 +45,629 | +74% | +$2.38M |
|
|
ABMD
94
DELISTED
Abiomed Inc
ABMD
| $5.58M | 0.21% | 32,716 | – | – |
|
95
IQVIA
IQV
$32.4B
| $5.53M | 0.21% | 35,815 +5,958 | +20% | +$921K |
|
|
GRTX
96
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $5.48M | 0.21% | +416,666 | New | +$5.48M |
|
97
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $5.48M | 0.21% | +53,773 | New | +$5.48M |
|
|
RETA
98
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.4M | 0.2% | +26,412 | New | +$5.4M |
|
99
Labcorp
LH
$23.1B
| $5.32M | 0.2% | 31,424 | – | – |
|
|
PVLA
100
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.25M | 0.2% | 1,449,269 | – | – |
|